Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

July 24, 2028

Study Completion Date

December 31, 2028

Conditions
Mycobacterium Avium Complex Pulmonary Disease
Interventions
DRUG

cordyceps sinesis capsule

cordyceps sinesis capsule 4 capsules tid po for 12 months

DRUG

cordyceps sinesis capsule placebo

cordyceps sinesis capsule placebo 4 capsules tid po for 12 months

Trial Locations (6)

Unknown

RECRUITING

Anhui Chest Hospital, Hefei

NOT_YET_RECRUITING

Beijing Chest Hospital, Capital Medical University, Beijing

RECRUITING

China-Japan Friendship Hospital, Beijing

NOT_YET_RECRUITING

Guangzhou Chest Hospital, Guangzhou

RECRUITING

Jiangxi Chest Hospital, Nanchang

NOT_YET_RECRUITING

Shanghai Pulmonary Hospital, Shanghai

All Listed Sponsors
collaborator

China-Japan Friendship Hospital

OTHER

collaborator

Shanghai Pulmonary Hospital, Shanghai, China

OTHER

collaborator

Jiangxi Chest Hospital

UNKNOWN

collaborator

Guangzhou Chest Hospital.

UNKNOWN

collaborator

Anhui Chest Hospital

OTHER

collaborator

Beijing Chest Hospital

OTHER

collaborator

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

INDUSTRY

lead

Bin Cao

OTHER

NCT07174076 - Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease | Biotech Hunter | Biotech Hunter